Database & Systems Committee

Catherine Beaucé (Chair)       Sanofi Aventis France
Silke Behrendt Boehringer Ingelheim Germany
Christina Fogh Nielsen Novo Nordisk Denmark
Petra Mannechez Bayer Schering Healthcare      Germany
Jacky Gossage Glaxosmithkline UK
Rebecca Leyland AstraZeneca UK
Axel Rocholl F.Hoffmann-La Roche Switzerland
Paw Trebbien Nycomed Denmark
Martina Pinterova UCB Belgium
Alan Harrison IMS UK
Bridget Wiseman IMS UK
Sarah Matthews IMS UK

                                      

Objectives

Ensure databases & systems provide the best suitable platform to do international secondary market research through partnership with the major global providers.

Activities

1. Regular meetings with core providers IMS HEALTH & CEGEDIM STRATEGIC DATA to discuss their databases & systems offerings (quality, reliability & service associated) and main development pathways (meet business data requirements, address changing market dynamics or make the best use of latest technologies). They represent a key communication channel between global secondary data providers and international secondary market research functions from pharmaco’s.

2. Share experiences & best practice in international secondary pharmaceutical market research area using any type of data : sales, medical or Promotional.

3. Identify current unmet needs of international pharmaceutical market research and share them with Syndicated Data Committee to cooperate on provider research.

The Committee consists of pharmaceutical international market research representatives and IMS & CSD representatives. Project teams may be formed to address specific needs and other providers may be invited to participate whenever appropriate. The Committee always welcomes new members from pharmaceutical industry to enlarge its knowledge & experience sharing.

Meetings

Background

The Database and Systems Committee’s aim is to investigate and monitor technologies and systems that may have an impact on the way we retrieve, store and manipulate secondary numerical data.  The committee has a primary focus on the IMS MIDAS database and associated systems but also aims to identify and influence suppliers of other systems that may bring benefits to the way we work with secondary data.